An analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Roy, Ashbeel ^a,b   Lara, Aline ^c   Guimarães, Diogo ^d   Pires, Rita ^a,e   Gomes, Eneas R ^c   Carter, David E ^a   Gomez, Marcus V ^d,e   Guatimosim, Silvia ^c   Prado, Vania F ^a,b   Prado, Marco A M ^a,b   Gros, Robert ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d Graduate Program Santa Casa   (Brazil)

^e FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PURINE NUCLEOSIDE PHOSPHORYLASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; HEART DISEASE; HEART MUSCLE CELL; LIPOGENESIS; MALE; MICROARRAY ANALYSIS; MOUSE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PARASYMPATHETIC TONE; SYMPATHETIC TONE; TRANSCRIPTION REGULATION;

ANIMALS; CHOLINERGIC AGENTS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEART; HOMOZYGOTE; ISOPROTERENOL; LIPIDS; MICE; MITOCHONDRIA; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PURINE-NUCLEOSIDE PHOSPHORYLASE; REPRODUCIBILITY OF RESULTS; SUPEROXIDES; SYNAPTIC TRANSMISSION; TRANSCRIPTION, GENETIC; UP-REGULATION; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

MUS;

EID: 84863088959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039997     Document Type: Article

References (41)

1. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, et al. (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621.
2. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, et al. (1992) Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J 67: 482-485.
3. Floras JS, (1993) Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 22: 72A-84A.
4. Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, et al. (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51: 601-612.
5. Lara A, Damasceno DD, Pires R, Gros R, Gomes ER, et al. (2010) Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 30: 1746-1756.
6. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, et al. (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124.
7. Okazaki Y, Zheng C, Li M, Sugimachi M, (2010) Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J Physiol Sci 60: 67-74.
8. Handa T, Katare RG, Kakinuma Y, Arikawa M, Ando M, et al. (2009) Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice. J Card Fail 15: 805-811.
9. Kanazawa H, Ieda M, Kimura K, Arai T, Kawaguchi-Manabe H, et al. (2010) Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest 120: 408-421.
10. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
11. Guatimosim S, Sobie EA, dos Santos Cruz J, Martin LA, Lederer WJ, (2001) Molecular identification of a TTX-sensitive Ca(2+) current. Am J Physiol Cell Physiol 280: C1327-1339.
12. Arch JR, Newsholme EA, (1978) The control of the metabolism and the hormonal role of adenosine. Essays Biochem 14: 82-123.
13. Ward JL, Sherali A, Mo ZP, Tse CM, (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275: 8375-8381.
14. Bone DB, Choi DS, Coe IR, Hammond JR, (2010) Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice. Am J Physiol Heart Circ Physiol 299: H847-856.
15. Abd-Elfattah AS, Jessen ME, Lekven J, Doherty NE 3rd, Brunsting LA, et al (1988) Myocardial reperfusion injury. Role of myocardial hypoxanthine and xanthine in free radical-mediated reperfusion injury. Circulation 78: III224-235.
16. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, et al. (2003) Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 67: 781-787.
17. Beetsch JW, Park TS, Dugan LL, Shah AR, Gidday JM, (1998) Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells. Brain Res 786: 89-95.
18. Berry CE, Hare JM, (2004) Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 555: 589-606.
19. Katz AM, (1993) Metabolism of the failing heart. Cardioscience 4: 199-203.
20. Davila-Roman VG, Vedala G, Herrero P, de las Fuentes L, Rogers JG, et al. (2002) Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40: 271-277.
21. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, et al. (2002) Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 106: 606-612.
22. Sack MN, Rader TA, Park S, Bastin J, McCune SA, et al. (1996) Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94: 2837-2842.
23. Olson RE, Schwartz WB, (1951) Myocardial metabolism in congestive heart failure. Medicine (Baltimore) 30: 21-41.
24. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS, (2008) Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118: 863-871.
25. Zimmerman TP, Gersten N, Miech RP, (1970) Adenine and Adenosine Metabolism in Liver. Proceedings of the American Association for Cancer Research 11: 87.
26. Deuticke B, Gerlach E, Dierkesmann R, (1966) [Decomposition of free nucleotides in the rat heart, skeletal muscle, brain and liver in oxygen deficiency]. Pflugers Arch Gesamte Physiol Menschen Tiere 292: 239-254.
27. Nees S, Herzog V, Becker BF, Bock M, Des Rosiers C, et al. (1985) The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 80: 515-529.
28. Gerlach E, Nees S, Becker BF, (1985) The vascular endothelium: a survey of some newly evolving biochemical and physiological features. Basic Res Cardiol 80: 459-474.
29. Sommerschild HT, Kirkeboen KA, (2000) Adenosine and cardioprotection during ischaemia and reperfusion-an overview. Acta Anaesthesiol Scand 44: 1038-1055.
30. Yamamoto M, (1978) Studies on free radical formation and respiratory function in mitochondria from experimentally-induced failing dog heart. Jpn Circ J 42: 1320-1322, 1385-1393.
31. Singal PK, Khaper N, Palace V, Kumar D, (1998) The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 40: 426-432.
32. Shizukuda Y, Buttrick PM, (2002) Oxygen free radicals and heart failure: new insight into an old question. Am J Physiol Lung Cell Mol Physiol 283: L237-238.
33. Hunt MJ, Aru GM, Hayden MR, Moore CK, Hoit BD, et al. (2002) Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 283: L239-245.
34. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, et al. (2000) The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 87: 1172-1179.
35. Zhang J, Ugurbil K, From AH, Bache RJ, (2000) Use of magnetic resonance spectroscopy for in vivo evaluation of high-energy phosphate metabolism in normal and abnormal myocardium. J Cardiovasc Magn Reson 2: 23-32.
36. van Bilsen M, Smeets PJ, Gilde AJ, van der Vusse GJ, (2004) Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc Res 61: 218-226.
37. Katz AM, (1998) Is the failing heart energy depleted? Cardiol Clin 16: 633-644, viii.
38. Stanley WC, Recchia FA, Lopaschuk GD, (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85: 1093-1129.
39. Rana OR, Schauerte P, Kluttig R, Schroder JW, Koenen RR, et al. (2010) Acetylcholine as an age-dependent non-neuronal source in the heart. Auton Neurosci 156: 82-89.
40. Kakinuma Y, Akiyama T, Sato T, (2009) Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium. FEBS J 276: 5111-5125.
41. Rocha-Resende C, Roy A, Resende R, Ladeira MS, Lara A, et al. (2012) Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals. J Mol Cell Cardiol.